Indicated for: chronic hepatitis B
Substance: entecavir (nucleoside/nucleotide reverse transcriptase inhibitor)
ATC: J05AF10 (Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors)
Entecavir is an antiviral medication used to treat chronic hepatitis B, a viral infection that affects the liver. This medicine works by inhibiting the replication of the hepatitis B virus, helping to reduce inflammation and protect liver function. Entecavir is usually taken as tablets, once daily, as directed by the doctor.
Treatment with entecavir requires regular monitoring, as it is important to assess the effectiveness of the therapy and detect any side effects. Patients should strictly follow the treatment schedule and not stop taking the medication without medical advice.
Side effects may include headaches, fatigue, nausea, dizziness, or digestive disturbances. In rare cases, allergic reactions or impaired kidney function may occur.
Entecavir is an effective treatment for controlling chronic hepatitis B, but it requires constant medical supervision to prevent complications and ensure the success of the therapy. Collaboration with the doctor is essential throughout the treatment.